Aktis Oncology, Inc. ($AKTS)
Filing Information
| Accession Number | 0001193125-26-300162 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 10, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
150,000
Total Value
$1,636,201.12
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jul 8, 2026 | Exercise/Conversion | 50,000 | $4.95 | $247,500.00 | 50,000 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jul 8, 2026 | Sale | 14,800 | $27.13 | $401,484.04 | 35,200 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jul 8, 2026 | Sale | 30,829 | $27.95 | $861,735.29 | 4,371 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jul 8, 2026 | Sale | 4,371 | $28.71 | $125,481.79 | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Jul 8, 2026 | Exercise/Conversion | 50,000 | $0.00 | $0.00 | 221,218 | Direct | โ | View Details |